Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.19 is 54% above its 5-year average of 0.77, near the low end of its 5-year range (0.05–10.86).
As of the fiscal period ended Tuesday, June 30, 2026. 38.75% above its 12-month average of 0.86.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.19.
QUICK RATIO (ACID-TEST)
1.19
QUICK RATIO (ACID-TEST) AVG TTM
0.86
QUICK RATIO (ACID-TEST) AVG 3Y
0.41
QUICK RATIO (ACID-TEST) AVG 5Y
0.77
QUICK RATIO (ACID-TEST) AVG 10Y
0.84
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+38.75%
CURRENT VS 3Y AVG
+192.82%
CURRENT VS 5Y AVG
+54.34%
CURRENT VS 10Y AVG
+41.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 772 covered companies
CURRENT VS SECTOR MEDIAN
-62.81%
vs the sector median at left
Market Cap
$17.30M
Quick Ratio (Acid-Test)
11.48
TTM Avg
10.71
3Y Avg
12.62
5Y Avg
10.43
Market Cap
$17.01M
Quick Ratio (Acid-Test)
6.03
TTM Avg
7.38
3Y Avg
5.70
5Y Avg
5.02
Market Cap
$16.76M
Quick Ratio (Acid-Test)
4.61
TTM Avg
2.49
3Y Avg
1.75
5Y Avg
2.54
Market Cap
$17.65M
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.83
3Y Avg
1.35
5Y Avg
1.29
Market Cap
$16.75M
Quick Ratio (Acid-Test)
1.96
TTM Avg
1.25
3Y Avg
1.80
5Y Avg
4.00
Market Cap
$16.40M
Quick Ratio (Acid-Test)
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$19.55M
Quick Ratio (Acid-Test)
0.20
TTM Avg
0.34
3Y Avg
6.34
5Y Avg
6.11
Market Cap
$18.65M
Quick Ratio (Acid-Test)
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $17.27M | 1.19 | 0.86 | 0.41 | 0.77 |
| Lipocine Inc. (LPCN)vs › | $17.30M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 6.03 | 7.38 | 5.70 | 5.02 |
| Palatin Technologies, Inc. (PTN)vs › | $16.76M | 4.61 | 2.49 | 1.75 | 2.54 |
| Cosmos Health Inc. (COSM)vs › | $17.65M | 0.92 | 0.83 | 1.35 | 1.29 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | 1.96 | 1.25 | 1.80 | 4.00 |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | 1.65 | 3.34 | 3.94 | 7.05 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.55M | 0.20 | 0.34 | 6.34 | 6.11 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 27.85 | 15.71 | 9.25 | 10.43 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.90M | 0.76 | 1.36 | 2.82 | 3.25 |
Quick Ratio
1.19
Excludes inventory
Current Ratio
1.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.19 |
| 2026-03-31 | 2.02 |
| 2025-12-31 | 0.17 |
| 2025-09-30 | 0.40 |
| 2025-06-30 | 0.50 |
| 2025-03-31 | 0.35 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.05 |
| 2024-06-30 | 0.55 |
| 2024-03-31 | 0.53 |
| 2023-12-31 | 0.44 |
| 2023-09-30 | 0.59 |
| 2023-06-30 | 0.84 |
| 2023-03-31 | 1.06 |
| 2022-12-31 | 1.06 |
| 2022-09-30 | 1.48 |
| 2022-06-30 | 1.81 |
| 2022-03-31 | 4.06 |
| 2021-12-31 | 10.86 |
| 2021-09-30 | 5.38 |
| 2021-06-30 | 8.69 |
| 2021-03-31 | 15.17 |
| 2020-12-31 | 0.89 |
| 2020-09-30 | 0.39 |
| 2020-06-30 | 0.36 |
| 2020-03-31 | 0.35 |
| 2019-12-31 | 0.55 |
| 2019-09-30 | 0.64 |
| 2019-06-30 | 0.78 |
| 2019-03-31 | 0.43 |
| 2018-12-31 | 0.77 |
| 2018-09-30 | 1.60 |
| 2018-06-30 | 2.38 |
| 2018-03-31 | 2.97 |
| 2017-12-31 | 0.64 |
| 2017-09-30 | 0.43 |
| 2017-06-30 | 0.04 |
| 2017-03-31 | 0.20 |
| 2016-12-31 | 0.62 |
| 2016-09-30 | 2.33 |
| 2016-06-30 | 7.78 |
| 2016-03-31 | 0.39 |
| 2015-12-31 | 1.34 |
| 2015-09-30 | 5.93 |
| 2015-06-30 | 6.17 |
| 2015-03-31 | 18.70 |
